eli lilly and company mounjaro - Search News

News

Eli Lilly hikes Mounjaro prices in the UK

CNN on MSN · 1d

Eli Lilly hikes Mounjaro prices in the UK to make weight-loss drug cheaper in the US

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.

The Globe and Mail · 2d

Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in other markets

Pharmaceutical Technology on M… · 1d

UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.

3d

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...

9don MSN

Eli Lilly is giving Novo Nordisk a run for its money—so why is LLY stock still down today?

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

1don MSN

Eli Lilly Mounjaro UK Price Increase Set To Soar By Up To 170%—Private Patients Facing £330 Monthly Costs

Eli Lilly will raise UK private prices for Mounjaro by up to 170 percent from September 2025, with the highest dose set to ...

The Indiana Lawyer4d

Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...

4d

Texas AG sues Eli Lilly for allegedly bribing medical providers to prescribe Lilly drugs

Texas Attorney General Ken Paxton alleges that Eli Lilly bribed Texas medical providers to provide the company's drugs. Eli Lilly denies the claims.

16don MSN

Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results